Impact of Timing of Antiretroviral Treatment and Birth Weight on Mother-to-Child Human Immunodeficiency Virus Transmission: Findings From an 18-Month Prospective Cohort of a Nationally Representative Sample of Mother–Infant Pairs During the Transition From Option A to Option B+ in Zimbabwe

Clicks: 279
ID: 112284
2018
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #20 of 1,084 articles by views in clinical infectious diseases

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 1,084 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Initiating antiretroviral treatment preconception and during early pregnancy could reduce 18-month mother-to-child HIV transmission in Zimbabwe to 3.0% and 5.1%
Reference Key
thu-ha2018clinicalimpact Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Dinh, Thu-Ha;Mushavi, Angela;Shiraishi, Ray W;Tippett Barr, Beth;Balachandra, Shirish;Shambira, Gerald;Nyakura, Justice;Zinyowera, Sekesai;Tshimanga, Mufuta;Mugurungi, Owen;Kilmarx, Peter H;
Journal clinical infectious diseases
Year 2018
DOI
DOI not found
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.